BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17178762)

  • 1. Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile.
    Fujikawa K; Aratake K; Kawakami A; Aramaki T; Iwanaga N; Izumi Y; Arima K; Kamachi M; Tamai M; Huang M; Nakamura H; Nishiura Y; Origuchi T; Ida H; Eguchi K
    Ann Rheum Dis; 2007 Jan; 66(1):136-7. PubMed ID: 17178762
    [No Abstract]   [Full Text] [Related]  

  • 2. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of genital ulcers with infliximab in Behcet's disease.
    Haugeberg G; Velken M; Johnsen V
    Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature.
    Pipitone N; Olivieri I; Padula A; D'angelo S; Nigro A; Zuccoli G; Boiardi L; Salvarani C
    Arthritis Rheum; 2008 Feb; 59(2):285-90. PubMed ID: 18240181
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M; Cinal A; Topcu N; Demirok A
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful long-term treatment of refractory Adamantiades-Behçet's disease (ABD) with infliximab: report of two patients.
    Katsiari CG; Theodossiadis PG; Kaklamanis PG; Markomichelakis NN; Sfikakis PP
    Adv Exp Med Biol; 2003; 528():551-5. PubMed ID: 12918762
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of infliximab in progressive neuro-Behçet's syndrome.
    Kikuchi H; Aramaki K; Hirohata S
    J Neurol Sci; 2008 Sep; 272(1-2):99-105. PubMed ID: 18550081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.
    Sugimura N; Mizoshita T; Sugiyama T; Togawa S; Miyaki T; Suzuki T; Tanida S; Kataoka H; Sasaki M
    Dig Liver Dis; 2019 Jul; 51(7):967-971. PubMed ID: 30872086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome.
    Licata G; Pinto A; Tuttolomondo A; Banco A; Ciccia F; Ferrante A; Triolo G
    Ann Rheum Dis; 2003 Mar; 62(3):280-1. PubMed ID: 12594127
    [No Abstract]   [Full Text] [Related]  

  • 10. Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behçet's disease.
    Andonopoulos AP; Meimaris N; Daoussis D; Bounas A; Yiannopoulos G
    Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S57-8. PubMed ID: 14727465
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis.
    Imabayashi K; Ayano M; Higashioka K; Yokoyama K; Yamamoto K; Takayama K; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    J Neuroimmunol; 2021 Aug; 357():577631. PubMed ID: 34153801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory neuro-Behçet treated by tocilizumab: a case report.
    Urbaniak P; Hasler P; Kretzschmar S
    Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S73-5. PubMed ID: 23020826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of severe Behçet's disease with anti-TNF-alpha: infliximab. A case report].
    Andreu M; Ramanoelina J; Fajnkuchen F; Mouthon L; Cohen P; Laroche L; Guillevin L
    Ann Med Interne (Paris); 2002 Oct; 153(6):414-5. PubMed ID: 12486393
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS; Gavin MP; Sturrock RD
    Adv Exp Med Biol; 2003; 528():557-9. PubMed ID: 12918763
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
    Park J; Cheon JH
    Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease.
    Ribi C; Sztajzel R; Delavelle J; Chizzolini C
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1733-5. PubMed ID: 16291906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab monotherapy for neuro-Behçet's disease: a case report.
    Di Filippo M; Di Gregorio M; Nannini C; Gaetani L; Gallina C; Floridi P; Sarchielli P; Calabresi P; Cantini F
    J Neurol Sci; 2014 Dec; 347(1-2):389-90. PubMed ID: 25456463
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
    Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
    [No Abstract]   [Full Text] [Related]  

  • 20. Infliximab in refractory uveitis due to Behçet's disease.
    Wechsler B; Sablé-Fourtassou R; Bodaghi B; Huong DL; Cassoux N; Badelon I; Fain O; LeHoang P; Piette JC
    Clin Exp Rheumatol; 2004; 22(4 Suppl 34):S14-6. PubMed ID: 15515776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.